Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Krystal Biotech (NASDAQ: KRYS) Awards Director 1,658 Derivative Securities

Krystal Biotech, Inc. (NASDAQ: KRYS) awarded Janney Daniel 1,658 derivative securities at $0 per share on 14 September 2026. Daniel is identified as a director of Krystal Biotech, Inc.

Vinay Lochav | 17 September 2026

LivaNova (NASDAQ: LIVN) Awards Chief Legal Officer 6,291 Derivative Securities

LivaNova PLC (NASDAQ: LIVN) awarded Chief Legal Officer Liddy Anne M. 6,291 derivative securities, with the transaction representing about 100.0% of her resulting derivative securities holding. The filing dates the transaction to September 15, 2026.

Vinay Lochav | 17 September 2026

Moderna (NASDAQ: MRNA) President Owned 1,602,310 Shares After Option Exercises

Moderna, Inc. (NASDAQ: MRNA) President Hoge Stephen exercised options for 152,905 shares at $12.21 per share across two transactions between 14 September 2026 and 15 September 2026. Following these transactions, he owned 1,602,310 shares.

Vinay Lochav | 17 September 2026

Myriad Genetics (NASDAQ: MYGN) Reaffirms 2026 Guidance Amid Commercial Leadership Change

Myriad Genetics Inc. (NASDAQ: MYGN) appointed Vishal Sikri as executive vice president, commercial, effective September 16, 2026.

Vinay Lochav | 17 September 2026

Phreesia (NYSE: PHR) Awards 6,490 Shares at $0 to HR SVP

Phreesia, Inc. (NYSE: PHR) awarded 6,490 shares at $0 per share to Amy Beth VanDuyn, its SVP, Human Resources. The award occurred on September 14, 2026.

Vinay Lochav | 17 September 2026

Azenta (NASDAQ: AZTA) Grants 4,586 Shares to Chief Accounting Officer

Azenta, Inc. (NASDAQ: AZTA) awarded Chief Accounting Officer Erik J. Bello 4,586 shares, creating a reported executive holding of the same size. The shares were awarded at $0 per share.

Vinay Lochav | 17 September 2026

Clene Inc. (NASDAQ: CLNN) Agrees $4M Stock Sale to Fund CNM-Au8 Work

Clene Inc. (NASDAQ: CLNN) agreed to issue and sell 1,219,513 shares of common stock at $3.28 per share, with gross proceeds expected to reach approximately $4.0 million. The plannedCapitalwould support regulatory dialogue and preparation of filings for lead drug candidate CNM-Au8, while also funding …

Vinay Lochav | 17 September 2026

CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ: CLOV) /DE Sells 300,000 Shares at $4.72

Wai Conrad, CEO of Counterpart Health, sold 300,000 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) at $4.72 per share on Sep. 15, 2026. The transaction involved CLOVER Health stock and was classified with transaction code S. The reported price was $4.72 per …

Vinay Lochav | 17 September 2026

Co-Diagnostics (NASDAQ: CODX) to Host Investor Presentation on ReadyGo Collaboration and Development Activities

Co-Diagnostics hosted an investor and analyst presentation on September 16, 2026, covering its ReadyGo Diagnostics collaboration, Co-Dx PCR platform, development activities,Manufacturinginitiatives and India operations. The presentation materials give investors the company’s stated agenda for its collaboration, platform development and operating initiatives.Key HighlightsDwight Egan signed …

Vinay Lochav | 17 September 2026

BRADLEY WILLIAM Buys 64,516 Fractyl Health Shares at $0.62

BRADLEY WILLIAM bought 64,516 shares of Fractyl Health, Inc. (NASDAQ: GUTS) at $0.62 per share on Sep. 14. The purchase represented about 43.3% of Bradley William’s resulting holding in Fractyl Health.

Vinay Lochav | 17 September 2026
Support

Hi! How can we help you today?

Loading…